HETEROBICYCLOARYL RORC2 INHIBITORS AND METHODS OF USE THEREOF
The present invention provides compounds, pharmaceutical compositions, methods of inhibiting RORy activity and/or reducing the amount of IL-17 in a subject, and methods of treating various medical disorders using such compounds and pharmaceutical compositions.
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; lit |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | ZAPF, Christoph Wolfgang XING, Li WENNERSTÅL, Göran Mattias SCHNUTE, Mark Edward KAILA, Neelu MEYERS, Marvin Jay BLINN, James Robert MENTE, Scot Richard THORARENSEN, Atli ZAMARATSKI, Edouard FLICK, Andrew Christopher JONES, Peter KIEFER, James Richard Jr KURUMBAIL, Ravi G |
| description | The present invention provides compounds, pharmaceutical compositions, methods of inhibiting RORy activity and/or reducing the amount of IL-17 in a subject, and methods of treating various medical disorders using such compounds and pharmaceutical compositions. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_LT3027603TT</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>LT3027603TT</sourcerecordid><originalsourceid>FETCH-epo_espacenet_LT3027603TT3</originalsourceid><addsrcrecordid>eNrjZLD1cA1xDfJ38nSOdPbxdwyK9FEI8g9yNlLw9PPwdPIM8Q8KVnD0c1HwdQ3x8HcJVvB3UwgNdlUI8XANcvV342FgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8T4hxgZG5mYGxiEhxkQoAQD2Win1</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>HETEROBICYCLOARYL RORC2 INHIBITORS AND METHODS OF USE THEREOF</title><source>esp@cenet</source><creator>ZAPF, Christoph Wolfgang ; XING, Li ; WENNERSTÅL, Göran Mattias ; SCHNUTE, Mark Edward ; KAILA, Neelu ; MEYERS, Marvin Jay ; BLINN, James Robert ; MENTE, Scot Richard ; THORARENSEN, Atli ; ZAMARATSKI, Edouard ; FLICK, Andrew Christopher ; JONES, Peter ; KIEFER, James Richard Jr ; KURUMBAIL, Ravi G</creator><creatorcontrib>ZAPF, Christoph Wolfgang ; XING, Li ; WENNERSTÅL, Göran Mattias ; SCHNUTE, Mark Edward ; KAILA, Neelu ; MEYERS, Marvin Jay ; BLINN, James Robert ; MENTE, Scot Richard ; THORARENSEN, Atli ; ZAMARATSKI, Edouard ; FLICK, Andrew Christopher ; JONES, Peter ; KIEFER, James Richard Jr ; KURUMBAIL, Ravi G</creatorcontrib><description>The present invention provides compounds, pharmaceutical compositions, methods of inhibiting RORy activity and/or reducing the amount of IL-17 in a subject, and methods of treating various medical disorders using such compounds and pharmaceutical compositions.</description><language>eng ; lit</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180810&DB=EPODOC&CC=LT&NR=3027603T$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180810&DB=EPODOC&CC=LT&NR=3027603T$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ZAPF, Christoph Wolfgang</creatorcontrib><creatorcontrib>XING, Li</creatorcontrib><creatorcontrib>WENNERSTÅL, Göran Mattias</creatorcontrib><creatorcontrib>SCHNUTE, Mark Edward</creatorcontrib><creatorcontrib>KAILA, Neelu</creatorcontrib><creatorcontrib>MEYERS, Marvin Jay</creatorcontrib><creatorcontrib>BLINN, James Robert</creatorcontrib><creatorcontrib>MENTE, Scot Richard</creatorcontrib><creatorcontrib>THORARENSEN, Atli</creatorcontrib><creatorcontrib>ZAMARATSKI, Edouard</creatorcontrib><creatorcontrib>FLICK, Andrew Christopher</creatorcontrib><creatorcontrib>JONES, Peter</creatorcontrib><creatorcontrib>KIEFER, James Richard Jr</creatorcontrib><creatorcontrib>KURUMBAIL, Ravi G</creatorcontrib><title>HETEROBICYCLOARYL RORC2 INHIBITORS AND METHODS OF USE THEREOF</title><description>The present invention provides compounds, pharmaceutical compositions, methods of inhibiting RORy activity and/or reducing the amount of IL-17 in a subject, and methods of treating various medical disorders using such compounds and pharmaceutical compositions.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2018</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLD1cA1xDfJ38nSOdPbxdwyK9FEI8g9yNlLw9PPwdPIM8Q8KVnD0c1HwdQ3x8HcJVvB3UwgNdlUI8XANcvV342FgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8T4hxgZG5mYGxiEhxkQoAQD2Win1</recordid><startdate>20180810</startdate><enddate>20180810</enddate><creator>ZAPF, Christoph Wolfgang</creator><creator>XING, Li</creator><creator>WENNERSTÅL, Göran Mattias</creator><creator>SCHNUTE, Mark Edward</creator><creator>KAILA, Neelu</creator><creator>MEYERS, Marvin Jay</creator><creator>BLINN, James Robert</creator><creator>MENTE, Scot Richard</creator><creator>THORARENSEN, Atli</creator><creator>ZAMARATSKI, Edouard</creator><creator>FLICK, Andrew Christopher</creator><creator>JONES, Peter</creator><creator>KIEFER, James Richard Jr</creator><creator>KURUMBAIL, Ravi G</creator><scope>EVB</scope></search><sort><creationdate>20180810</creationdate><title>HETEROBICYCLOARYL RORC2 INHIBITORS AND METHODS OF USE THEREOF</title><author>ZAPF, Christoph Wolfgang ; XING, Li ; WENNERSTÅL, Göran Mattias ; SCHNUTE, Mark Edward ; KAILA, Neelu ; MEYERS, Marvin Jay ; BLINN, James Robert ; MENTE, Scot Richard ; THORARENSEN, Atli ; ZAMARATSKI, Edouard ; FLICK, Andrew Christopher ; JONES, Peter ; KIEFER, James Richard Jr ; KURUMBAIL, Ravi G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_LT3027603TT3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; lit</language><creationdate>2018</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ZAPF, Christoph Wolfgang</creatorcontrib><creatorcontrib>XING, Li</creatorcontrib><creatorcontrib>WENNERSTÅL, Göran Mattias</creatorcontrib><creatorcontrib>SCHNUTE, Mark Edward</creatorcontrib><creatorcontrib>KAILA, Neelu</creatorcontrib><creatorcontrib>MEYERS, Marvin Jay</creatorcontrib><creatorcontrib>BLINN, James Robert</creatorcontrib><creatorcontrib>MENTE, Scot Richard</creatorcontrib><creatorcontrib>THORARENSEN, Atli</creatorcontrib><creatorcontrib>ZAMARATSKI, Edouard</creatorcontrib><creatorcontrib>FLICK, Andrew Christopher</creatorcontrib><creatorcontrib>JONES, Peter</creatorcontrib><creatorcontrib>KIEFER, James Richard Jr</creatorcontrib><creatorcontrib>KURUMBAIL, Ravi G</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ZAPF, Christoph Wolfgang</au><au>XING, Li</au><au>WENNERSTÅL, Göran Mattias</au><au>SCHNUTE, Mark Edward</au><au>KAILA, Neelu</au><au>MEYERS, Marvin Jay</au><au>BLINN, James Robert</au><au>MENTE, Scot Richard</au><au>THORARENSEN, Atli</au><au>ZAMARATSKI, Edouard</au><au>FLICK, Andrew Christopher</au><au>JONES, Peter</au><au>KIEFER, James Richard Jr</au><au>KURUMBAIL, Ravi G</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>HETEROBICYCLOARYL RORC2 INHIBITORS AND METHODS OF USE THEREOF</title><date>2018-08-10</date><risdate>2018</risdate><abstract>The present invention provides compounds, pharmaceutical compositions, methods of inhibiting RORy activity and/or reducing the amount of IL-17 in a subject, and methods of treating various medical disorders using such compounds and pharmaceutical compositions.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; lit |
| recordid | cdi_epo_espacenet_LT3027603TT |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | HETEROBICYCLOARYL RORC2 INHIBITORS AND METHODS OF USE THEREOF |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T06%3A43%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ZAPF,%20Christoph%20Wolfgang&rft.date=2018-08-10&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ELT3027603TT%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |